Sandoz Group AG (SDZXF)

Market Cap	31.99B
Revenue (ttm)	10.59B
Net Income (ttm)	227.00M
Shares Out	n/a
EPS (ttm)	0.52
PE Ratio	140.91
Forward PE	20.33
Dividend	0.73 (1.03%)
Ex-Dividend Date	Apr 17, 2025

Volume	221
Average Volume	273
Open	71.29
Previous Close	n/a
Day's Range	71.29 - 71.29
52-Week Range	36.68 - 72.92
Beta	0.26
RSI	73.78
Earnings Date	Feb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1886
• Employees: 22,049
• Stock Exchange: OTCMKTS
• Ticker Symbol: SDZXF